France: price limit for huge range of orthoprostheses:
This article was originally published in Clinica
Executive Summary
The French healthcare products economics committee, CEPS, which decides on reimbursement levels for devices used in the private sector, has entered into a huge price/volume agreement with the French union of manufacturers of orthoprostheses. The result is 30 pages of price limits for these products, as shown in the Journal officiel. The list fixes not only the price that the reimbursement authorities will pay for the products, but also the maximum price of the products when sold to the public. The contract was published in the JO of March 4, and takes effect 30 days later.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.